• PPT (Propyl Pyrazole Triol): Advancing ERα-Selective Sign...

  2025-10-23

  Explore how PPT (Propyl Pyrazole Triol), a selective ERα agonist, is revolutionizing hormone receptor research and biomarker systems biology. This article uniquely dissects the molecular mechanism, translational applications, and systems-level modeling enabled by PPT for estrogen receptor alpha signaling.

• PPT: Selective ERα Agonist Transforming Hormone Receptor ...

  2025-10-22

  PPT (Propyl Pyrazole Triol) stands out as the gold-standard ERα selective ligand for dissecting estrogen receptor signaling in both cancer and developmental biology. Its robust selectivity and solubility unlock reproducible, high-fidelity results across cell-based and in vivo models, streamlining advanced research in breast cancer, lung adenocarcinoma, and hormone receptor biology.

• Gap26: Dissecting Connexin 43 Blockade in Immune & Vascul...

  2025-10-21

  Explore the advanced scientific mechanisms of Gap26, a leading connexin 43 mimetic peptide, and its unique role as a gap junction blocker peptide in immune modulation and vascular smooth muscle research. This article delves deeper into its translational impact on neuroprotection and inflammation, building beyond existing resources.

3 records 1/1 page